Skip to content

CareDx

US · CDNA #2371 by market cap Listed 1970
70.00 -1.92 -2.67%
Periodic snapshot; not a real-time feed. · 2026-11-20 20:02

Price chart

Pre-market 70.17 -2.43%
After-hours 69.79 -0.30%
Overnight 71.89 -0.04%
88.4721.5470.002026-05-262026-11-20
MA5MA10MA20MA60
— MA5 — MA10 — MA20 — MA60
Reader sentiment Are you bullish or bearish on CDNA?

Anonymous reader poll. Unscientific, not investment advice.

✦ StockVane Quant Insights how this is computed

Quant Sentiment Bullish
  • Recent price momentum is +196.6% on average (3-month/1-year).
  • Main-fund capital flow has been a net outflow over the last 45 sessions.
  • Short interest has risen to 13.7% of float.
  • Analyst tilt is Buy.
Quant Technical Outlook Neutral
  • Price is below its 20-day average and above its 60-day average.
  • The 20-day average is above the 60-day average, a short-term uptrend.
Quant Rating, last 30 days A → C

Computed by a StockVane algorithm from historical price, valuation and analyst data - not a person, not a forecast guarantee, and not investment advice.

Factor grades

Ranked against 2848 U.S. stocks StockVane covers.

Last computed: 2026-11-22 08:27 UTC

Data coverage: 5 of 6 factors. Missing data is not a zero score.

Overall C

The radar needs all six factors. Available grades are shown below.

Valuation F

How expensive the stock is versus earnings, sales and its own 5-year history.

P/E (TTM) 29.5x Better than 23%
Forward P/E 141.7x Better than 2%
Price / Sales 8.2x Better than 13%
P/E vs own 5-yr range 99th pctl Better than 5%
Growth N/A

How fast revenue, profit and free cash flow are compounding.

Not enough data to grade this factor.

Profitability C

How much profit the business keeps from each dollar of sales and capital.

Gross margin 67.6% Better than 81%
Operating margin -6.6% Better than 16%
Net margin -5.6% Better than 19%
Return on equity -6.3% Better than 22%
Return on invested capital -7.7% Better than 19%
Momentum A+

Recent price strength, skipping the latest month to avoid short-term noise.

3-month return 44.0% Better than 99%
6-month return 223.6% Better than 100%
12-month return (ex latest month) 302.9% Better than 100%
Distance below 52-week high 23.0% Better than 54%
Financial Health B

Balance-sheet strength: leverage, liquidity and interest coverage.

Current ratio 2.9x Better than 71%
Debt to assets 6.3% Better than 76%
Free cash flow / net income 60.1% Better than 17%
Analyst View B-

What the Street thinks: share of Buy ratings and upside to the average target.

Analysts rating Buy 75.0% Better than 51%
Upside to average target 32.1% Better than 51%

Grades are relative rankings, not forecasts: A+ is the top 5% of the covered stocks on a factor, F the bottom 3%. Valuation is not adjusted for sector. Background recomputation is scheduled every 6 hours; actual computation time is shown above, and source datasets have different reporting dates. Not investment advice or tailored to your financial situation.

Performance

1W -10.12%
1M +1.16%
3M +48.97%
6M +230.97%
YTD +271.55%
1Y +344.16%
3Y +623.14%
5Y +62.75%

Key statistics

Price & volume

Prev close
71.92
Open
70.56
Day range
69.26 - 72.94
Avg price
70.36
Volume
782.02K
Turnover
55.02M
Amplitude
5.12%
52-week range
15.56 - 90.87

Valuation

P/E
-175.00
P/E (TTM)
29.54
P/B
7.87
EPS
-0.40
Net profit
-21.02M
Net assets
467.47M

Share structure

Market cap
3.68B
Float cap
3.56B
Shares out
52.54M
Float shares
50.82M

Dividend & listing

Dividend (TTM)
0.00
Listing date
1970-01-01
52-week range 72% of range
15.56 90.87

23.0% below the 52-week high

Trading activity

Net capital flow main funds, last 45 sessions

-7.03M net over the window

Short interest

Shares short
7.19M
As of
2026-10-30

Frequently asked questions

What is the current stock price of CareDx (CDNA)?

CareDx last traded at 70.00. This page shows a periodic quote snapshot. Check the displayed quote time.

What is CareDx's market cap?

About 3.68B.

What is the P/E ratio of CareDx?

The trailing twelve-month P/E is 29.54. The Valuation tab shows it against the stock's own five-year range.

Does CareDx pay a dividend?

CareDx does not currently pay a regular dividend.

Is CareDx a buy according to analysts?

The consensus of 4 analysts is a Buy rating, with an average 12-month price target of 92.50, which implies 32.1% upside from the current price. This is not investment advice.

What is CareDx's StockVane Quant Rating?

The StockVane Momentum strategy currently rates CareDx a C (Hold). Mid-pack momentum — held if you own it, not a fresh buy. Not investment advice.

Quote time 2026-11-20 20:02:25 · For reference only, not investment advice and not tailored to your situation.

CareDx discussion 0 comments

Add a comment